Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Calvo

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Leukemia Research|December 13, 2021
Monocyte subset distribution in myeloproliferative and myelodysplastic/myeloproliferative neoplasms with monocytosisMarc Sorigue, Leonor Arenillas, Blanca Xicoy, et al.
Leukemia Research|September 11, 2015
Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of prognostic factors in CMMLXavier Calvo, Meritxell Nomdedeu, Rodrigo Santacruz, et al.
Leukemia Research|June 2, 2014
High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndromeXavier Calvo, Meritxell Nomdedeu, Alfons Navarro, et al.
Journal of Cutaneous Pathology|October 31, 2025
Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell PhenotypeNidia Planella-Fontanillas, Andrea Molina-Alvarez, Lluís Colomo-Saperas, et al.
Acta Haematologica|October 29, 2015
Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic SyndromesDolors Costa, Concha Muñoz, Ana Carrió, et al.
International Journal of Laboratory Hematology|December 13, 2022
Inactive T-cell prolymphocytic leukemia with negative surface CD3: Cytogenetic pitfallsMarie Solange Flores-Morán, Juan José Rodríguez-Sevilla, Leonor Arenillas, et al.
Cancer Cell International|December 24, 2015
Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stromaMeritxell Nomdedeu, María Carmen Lara-Castillo, Amaia Etxabe, et al.
International Journal of Laboratory Hematology|August 3, 2023
Sex-associated differences in genomic profile of chronic myelomonocytic leukemia involving differential representation of SRSF2 gene mutationXavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, et al.
Leukemia Research|July 19, 2011
Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutationMeritxell Nomdedeu, Margherita Maffioli, Xavier Calvo, et al.
British Journal of Haematology|September 18, 2020
Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasmsNieves Garcia-Gisbert, Lierni Fernández-Ibarrondo, Concepcion Fernández-Rodríguez, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Leukemia Research|December 13, 2021
Monocyte subset distribution in myeloproliferative and myelodysplastic/myeloproliferative neoplasms with monocytosisMarc Sorigue, Leonor Arenillas, Blanca Xicoy, et al.
Leukemia Research|September 11, 2015
Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of prognostic factors in CMMLXavier Calvo, Meritxell Nomdedeu, Rodrigo Santacruz, et al.
Leukemia Research|June 2, 2014
High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndromeXavier Calvo, Meritxell Nomdedeu, Alfons Navarro, et al.
Journal of Cutaneous Pathology|October 31, 2025
Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell PhenotypeNidia Planella-Fontanillas, Andrea Molina-Alvarez, Lluís Colomo-Saperas, et al.
Acta Haematologica|October 29, 2015
Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic SyndromesDolors Costa, Concha Muñoz, Ana Carrió, et al.
International Journal of Laboratory Hematology|December 13, 2022
Inactive T-cell prolymphocytic leukemia with negative surface CD3: Cytogenetic pitfallsMarie Solange Flores-Morán, Juan José Rodríguez-Sevilla, Leonor Arenillas, et al.
Cancer Cell International|December 24, 2015
Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stromaMeritxell Nomdedeu, María Carmen Lara-Castillo, Amaia Etxabe, et al.
International Journal of Laboratory Hematology|August 3, 2023
Sex-associated differences in genomic profile of chronic myelomonocytic leukemia involving differential representation of SRSF2 gene mutationXavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, et al.
Leukemia Research|July 19, 2011
Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutationMeritxell Nomdedeu, Margherita Maffioli, Xavier Calvo, et al.
British Journal of Haematology|September 18, 2020
Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasmsNieves Garcia-Gisbert, Lierni Fernández-Ibarrondo, Concepcion Fernández-Rodríguez, et al.
Pageof 6